Clinical Trials on Malignant Neoplasms of Thyroid and Other Endocrine Glands in Japan
Total 186 results
-
Osaka UniversityRecruitingThyroid CancerJapan
-
Eisai Co., Ltd.Completed
-
BayerActive, not recruiting
-
Eisai Co., Ltd.Completed
-
BayerCompletedThyroid CarcinomaJapan
-
National Cancer Center Hospital EastOno Pharmaceutical Co. LtdActive, not recruitingAnaplastic Thyroid CancerJapan
-
Genzyme, a Sanofi CompanyCompletedUnresectable Locally Advanced or Metastatic, Medullary Thyroid CarcinomaJapan
-
Loxo Oncology, Inc.Eli Lilly and CompanyAvailableBreast Cancer | Pancreatic Cancer | Non Small Cell Lung Cancer | Colon Cancer | Medullary Thyroid Cancer | Papillary Thyroid Cancer | Other Solid Tumors With Evidence of Activating RET AlterationSpain, United States, Australia, France, Germany, Israel, Italy, Japan, New Zealand, Poland, Singapore, Switzerland
-
BayerCompletedThyroid NeoplasmsUnited States, Japan, Turkey, Russian Federation, India, Germany, France, Mexico, Philippines, Greece, Netherlands, Spain, Taiwan, Brazil, Egypt, Argentina, Algeria, Lebanon, Saudi Arabia
-
Genzyme, a Sanofi CompanyCompletedEvaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid Cancer (VERIFY)Differentiated Thyroid CancerUnited States, Sweden, Brazil, Italy, Poland, Spain, China, Russian Federation, France, Japan, Denmark, Czechia
-
Translational Research Center for Medical Innovation...CompletedAnaplastic Thyroid CancerJapan
-
BayerAmgenCompletedThyroid NeoplasmsFrance, China, Korea, Republic of, United States, Spain, Russian Federation, United Kingdom, Netherlands, Sweden, Austria, Italy, Bulgaria, Poland, Saudi Arabia, Germany, Japan, Belgium, Denmark
-
Ito HospitalCompletedThyroid Disease | Parathyroid DiseaseJapan
-
Eisai Inc.CompletedThyroid CancerUnited States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Czechia, Denmark, France, Germany, Italy, Japan, Korea, Republic of, Poland, Portugal, Romania, Russian Federation, Spain, Sweden, Thailand, United Kingdom
-
Loxo Oncology, Inc.Eli Lilly and CompanyActive, not recruitingMedullary Thyroid CancerUnited States, Canada, Spain, China, Taiwan, Australia, Japan, India, Belgium, Germany, France, Netherlands, Czechia, Brazil, Korea, Republic of, United Kingdom, Italy, Israel, Greece, Poland, Russian Federation
-
Loxo Oncology, Inc.Eli Lilly and CompanyRecruitingSoft Tissue Sarcoma | Medullary Thyroid Cancer | Papillary Thyroid Cancer | Infantile Fibrosarcoma | Infantile MyofibromatosisUnited States, Australia, Japan, Canada, Germany, Korea, Republic of, France, Spain, United Kingdom, Denmark, Italy
-
Daiichi Sankyo Co., Ltd.AstraZenecaCompletedMalignant Neoplasm of BreastJapan
-
Mie UniversityCompleted
-
Nihon Pharmaceutical Co., LtdRecruitingAutoimmune EncephalitisJapan
-
Wakayama Medical UniversityUnknown
-
Osaka Medical Center for Cancer and Cardiovascular...CompletedPancreatic CancerJapan
-
Fukushima Medical UniversityUnknown
-
Osaka Medical Center for Cancer and Cardiovascular...CompletedPancreatic CancerJapan
-
Japan Clinical Cancer Research OrganizationCompleted
-
Invitae CorporationNational Cancer Center Hospital EastRecruiting
-
Wakayama Medical UniversityUnknown
-
Chiba UniversityUnknownPancreatic Tumor | Bile Duct TumorJapan
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompleted
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoUnknown
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoUnknown
-
Eli Lilly and CompanyCompleted
-
Hokkaido Gastrointestinal Cancer Study GroupHokkaido University HospitalSuspendedPancreatic CancerJapan
-
Merck KGaA, Darmstadt, GermanyThreshold PharmaceuticalsCompletedPancreatic Cancer | Solid TumorJapan
-
Nagoya UniversityJapan Agency for Medical Research and DevelopmentRecruiting
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoUnknownPancreatic Cancer | Pancreas NeoplasmsJapan
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoTerminatedPancreatic Cancer | Pancreas NeoplasmsJapan
-
BayerActive, not recruitingLiver Metastases | Metastatic Pancreatic Cancer | Gadoxetate Sodium-enhanced Magnetic Resonance ImagingJapan
-
Wakayama Medical UniversityCompletedPancreatic CancerJapan
-
Taewoong Medical Co., Ltd.CompletedPancreatic Cancer | Cancer of Bile DuctKorea, Republic of, Japan
-
Wakayama Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompletedPancreatic CancerJapan
-
Kyowa Kirin Co., Ltd.CompletedPrimary Hyperparathyroidism | Parathyroid CarcinomaJapan
-
Kyowa Kirin Co., Ltd.CompletedPrimary Hyperparathyroidism | Parathyroid Carcinoma | HypercalcemiaJapan
-
NantCell, Inc.TakedaTerminatedCancer | Pancreatic Cancer | Advanced Solid Tumors | Metastatic Cancer | Bone Metastases | Solid Tumors | Pancreas Cancer | Adenocarcinoma of the Pancreas | Oncology | Cancer of Pancreas | Metastatic Pancreatic Cancer | Metastases | Cancer of the Pancreas | Advanced Malignancy | Oncology Patients | Endocrine CancerItaly, Spain, United Kingdom, Belgium, Canada, Denmark, Romania, United States, Germany, Netherlands, Korea, Republic of, Russian Federation, Australia, Austria, Lithuania, Portugal, Greece, Poland, Switzerland, Serbia, Bulgaria, ... and more
-
Sanwa Kagaku Kenkyusho Co., Ltd.CompletedSecondary HyperparathyroidismJapan
-
Kumamoto UniversityCompletedSecondary HyperparathyroidismJapan
-
Kyowa Kirin Co., Ltd.CompletedSecondary HyperparathyroidismJapan